Digital Therapeutics (DTx)

At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials

This white paper from Castor explores the importance of choosing an EDC with an API before starting a clinical trial.

Tech tools help Digital Therapeutics (DTx) maximize the impact of the real-world data they capture, explore how in this blog from Castor

Digital Therapeutics (DTx) is a rapidly growing space whose players are facing challenges in scaling their businesses, including testing. Learn more about growing successfully.

Cybersecurity has become a concern for Digital Therapeutics (DTx) developers and regulatory bodies. Learn to balance functionality & security.

A robust digital therapeutics cybersecurity system is integral to protecting users’ sensitive information helps meet regulatory requirements and maintain public trust.

DTx represent an emerging field of software-driven, evidence-based products intended to “prevent, manage, or treat a medical disease or disorder.” Cybersecurity is a concern for DTx, whether they are being evaluated through clinical research or are aiming at market release.